Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company focused on infectious disease, today announced it has appointed Mitchel Sayare, Ph.D., as Executive Chairman of the Board, effective immediately.
{iframe}https://www.nasdaq.com/press-release/altimmune-appoints-mitchel-sayare-as-executive-chairman-of-the-board-and-adds-jos-ochoa-to-its-20180710-00429{/iframe}